UPDATE : Tuesday, September 17, 2019
상단여백
Yuhan to expand biz scope to central nervous system disease
“We will broaden open innovation toward the academic sector and expand our ...
by Jeong Sae-im  |  2019-09-06 14:56
라인
Seoul Pharmaceutical to export erectile dysfunction treatment to Taiwan
Seoul Pharmaceutical said that it would export $4.9 million worth of its or...
by Lee Han-soo  |  2019-09-05 17:04
라인
Lilly’s migraine treatment Emgality lands in Korea
Lilly’s new migraine treatment Emgality Prefilled Pen Inj. (ingredient: gal...
by Lee Hye-seon  |  2019-09-05 16:24
라인
Daewoong, Medytox squabble over appraisal of additional spore for Nabota
Daewoong Pharmaceutical said that a recent test by the U.S. International T...
by Lee Han-soo  |  2019-09-05 14:35
라인
[News analysis] Takeda Korea’s merger with Shire has to surmount big hurdle; labor union
Takeda Korea, which took over Shire Korea in January according to their hea...
by Lee Han-soo  |  2019-09-04 17:06
라인
JW Pharmaceutical acquires Vietnamese drugmaker
JW Pharmaceutical said that it has taken over Euvipharm, a Vietnamese pharm...
by Lee Han-soo  |  2019-09-04 15:16
라인
Takeda Korea vows to release 16 new drugs by 2023
Takeda Pharmaceutical Korea on Tuesday held the first news conference after...
by Kim Yun-mi  |  2019-09-03 15:40
라인
SK goes global by developing new drugs, conducting CDMO biz
SK Holdings is integrating three pharmaceutical production subsidiaries aro...
by Jeong Sae-im  |  2019-09-03 14:58
라인
Hanmi, Daewoong among 20 innovative top-tier drugmakers in Asia Pacific
Hanmi Pharmaceutical and Daewoong Pharmaceutical were included in the top 2...
by Jeong Sae-im  |  2019-09-02 17:33
라인
Antidiabetic Forxiga proves efficacy in heart failure
AstraZeneca said it has confirmed that its diabetes drug Forxiga (ingredien...
by Kim Yun-mi  |  2019-09-02 11:35
라인
Daewoong, Medytox differ in interpreting spore appraisal for Nabota
Daewoong Pharmaceutical said Friday that it has gained the upper hand in th...
by Lee Han-soo  |  2019-08-30 16:26
라인
Atopic dermatitis patients fall in despair as Dupixent may not get coverage soon
Sanofi’s new biologic agent Dupixent (ingredient: dupilumab) for severe ato...
by Kim Yun-mi  |  2019-08-30 16:26
라인
Doctors seem less eager to participate in ‘No-Japan’ campaign. Why?
The boycott of Japanese products has been intensifying over the past few mo...
by Lee Han-soo  |  2019-08-30 15:58
라인
JW Pharmaceutical’s hyperlipidemia drug Livalo safe from diabetes risk
JW Pharmaceutical said more countries have recognized that its cholesterol-...
by Jeong Sae-im  |  2019-08-30 14:49
라인
'Mucosa healing essential for treating inflammatory bowel disease'
Takeda's Kynteles (Ingredient: Vedolizumab) is attempting a paradigm sh...
by Lee Han-soo  |  2019-08-30 12:42
라인
CAR-T therapy Kymriah, pie in the sky for Korean patients
Kymriah, Novartis’ new CAR-T (chimeric antigen receptor T-cell) treatment, ...
by Kim Yun-mi  |  2019-08-29 14:35
라인
Ildong’s subsidiary secures 1st anticancer drug pipeline
Idience, a subsidiary of Ildong Pharmaceutical, has acquired IDX-1197, an i...
by Lee Han-soo  |  2019-08-29 13:37
라인
Prosecutors raid Sillajen over alleged use of undisclosed information
The prosecution on Wednesday carried out simultaneous raids on Sillajen'...
by Lee Han-soo  |  2019-08-29 11:27
라인
Antidiabetic DPP-4 inhibitors mark double-digit sales growth
Inhibitors of dipeptidyl peptidase 4 (DPP-4), used to treat diabetes, have ...
by Jeong Sae-im  |  2019-08-29 11:24
라인
Crystal Genomics' immunotherapy gets orphan drug status from US regulator
Crystal Genomics' CG-745, a molecular immunotherapy for pancreatic canc...
by Lee Han-soo  |  2019-08-28 17:44
여백
여백
여백
Back to Top